MedTrace Logo

Natural History of Cytomegalovirus (CMV) Infection and Disease Among Renal Transplant Recipients

NCT01833416 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2015-03-23

No results posted yet for this study

Summary

Although the accumulated knowledge regarding Cytomegalovirus (CMV) infection increased substantially over the past years, several issues still deserve further investigation. The epidemiology of this disease has been changing, perhaps influenced by new immunosuppressive strategies currently used and growing and widespread use of prophylaxis. The knowledge of the CMV viral load kinetics, using a polymerase chain reaction (PCR-based assay), among renal transplant recipients not receiving any prophylactic therapy will allow the determination of risk factors for and the impact of earlier intervention on CMV infection and disease. The goal is to ultimately improve the clinical outcomes for renal transplant recipients.

Conditions

  • Infection in Solid Organ Transplant Recipients

Sponsors & Collaborators

  • Helio Tedesco Silva Junior

    lead OTHER

Principal Investigators

  • Helio T Silva-Junior, MD · Hospital do Rim e Hipertensao

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2014-04-30
Completion
2014-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01833416 on ClinicalTrials.gov